Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Steroid Treatment for Immunotherapy-Induced Pneumonitis

Grade-Based Treatment Algorithm

  • For symptomatic immunotherapy-induced pneumonitis (grade 2 or higher), the Society for Immunotherapy of Cancer recommends initiating methylprednisolone 1 mg/kg/day (IV or oral equivalent) immediately after holding the immune checkpoint inhibitor and ruling out infection 1, 2, 3
  • For grade 1 pneumonitis, hold the immune checkpoint inhibitor and monitor closely, with no steroids required at this stage, and reimage at least every 3 weeks 1, 3
  • For grade 2 pneumonitis, permanently hold the immune checkpoint inhibitor and initiate methylprednisolone 1 mg/kg/day (IV or oral equivalent), with consideration of hospitalization for pulmonary and infectious disease consultation 1, 2, 3
  • For grade 3-4 pneumonitis, permanently discontinue the immune checkpoint inhibitor, hospitalize immediately, and consider ICU-level care, with initiation of methylprednisolone IV 2 mg/kg/day 1, 2, 3

Critical Supportive Care Measures

  • The Society for Immunotherapy of Cancer recommends pneumocystis jirovecii pneumonia (PCP) prophylaxis for patients receiving ≥20 mg methylprednisolone equivalent for ≥4 weeks 1, 2, 3
  • Proton pump inhibitor therapy is recommended for GI prophylaxis in all patients with grade 2-4 pneumonitis receiving steroids 1, 2, 3
  • T-spot testing is recommended to exclude tuberculosis before initiating anti-TNF therapy 1, 2, 3
  • Calcium and vitamin D supplementation is recommended with prolonged steroid use 1, 2, 3

Infectious Workup

  • Nasal swab, sputum culture and sensitivity, blood culture and sensitivity, urine culture and sensitivity, and COVID-19 evaluation per institutional guidelines are recommended for grade 2 or higher pneumonitis 5
  • Pulse oximetry and CT chest (preferably with contrast if concerned for pulmonary embolus) are also recommended 5

Common Pitfalls to Avoid

  • The Society for Immunotherapy of Cancer recommends against using high-dose corticosteroids (1 mg/kg/day) for endocrine immune-related adverse events (thyroid, diabetes) 1
  • Delaying steroid initiation in symptomatic patients while awaiting bronchoscopy results is not recommended 1, 2, 3
  • Tapering steroids too quickly is not recommended, with grade 2 requiring >1 month taper and grade 3-4 requiring >2 months 1, 2, 3, 6